Elaine A. C. Albers

Elaine A. C. Albers

Auto-generated profile, based on publicly available information

Elaine A. C. Albers

Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2022 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
EAElaine A. C. Albers
Elaine A. C. Albers
IFItske Fraterman
Itske Fraterman
IWIris Walraven
Iris Walraven
EWErica Andrea Wilthagen
Erica Andrea Wilthagen
SSSanne B. Schagen
Sanne B. Schagen
KLKelly M. de Ligt
Kelly M. de Ligt
Purpose: The use of Patient-Reported Outcome Measures (PROMs) for individual patient management within clinical practice is becoming increasingly important. New evidence about graphic visualization formats for PROMs scores has become available. This systematic literature review evaluated evidence for graphic visualization formats of PROMs data in clinical practice for patients and clinicians, for both individual and group level PROMs data. Methods: Studies published between 2000 and 2020 were extracted from CINAHL, PubMed, PsychInfo, and Medline. Studies included patients ≥ 18 years old in daily clinical practice. Papers not available in English, without full-text access, or that did not specifically describe visualization of PROMs data were excluded. Outcomes were: visualization preferences; interpretation accuracy; guidance for clinical interpretation. Results: Twenty-five out of 789 papers were included for final analysis. Most frequently studied formats were: bar charts, line graphs, and pie charts. Patients preferred bar charts and line graphs as these were easy and quick for retrieving information about their PROMs scores over time. Clinicians’ interpretation accuracy and preferences were similar among graphic visualization formats. Scores were most often compared with patients’ own previous scores; to further guide clinical interpretation, scores were compared to norm population scores. Different ‘add-ons’ improved interpretability for patients and clinicians, e.g. using colors, descriptions of measurement scale directionality, descriptive labels, and brief definitions. Conclusion: There was no predominant graphical visualization format approach in terms of preferences or interpretation accuracy for both patients and clinicians. Detailed clarification of graph content is essential.

26 April 2024 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
EAE. A. C. Albers
E. A. C. Albers
JKJ. M. Kieffer
J. M. Kieffer
SSS. B. Schagen
S. B. Schagen

1 December 2022 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
EAElaine A. C. Albers
Elaine A. C. Albers
MRMichiel B. de Ruiter
Michiel B. de Ruiter
LPLonneke V. van de Poll-Franse
Lonneke V. van de Poll-Franse
LMLaura G. Merckel
Laura G. Merckel
ACAnnette Compter
Annette Compter
SSSanne B. Schagen
Sanne B. Schagen

24 March 2023 in JTO Clinical and Research Reports
Verified
Journal Article
Open access
EAElaine A.C. Albers
Elaine A.C. Albers
HZHaiyan Zeng
Haiyan Zeng
DRDirk K.M. De Ruysscher
Dirk K.M. De Ruysscher
MKMarianne A. Kuenen
Marianne A. Kuenen
RKRob Kessels
Rob Kessels
SSSanne B. Schagen
Sanne B. Schagen
In the randomized controlled trial in patients with SCLC comparing standard prophylactic cranial irradiation (PCI) with hippocampal avoidance PCI (HA-PCI), we did not observe beneficial effects of HA-PCI on tested cognition. Here, we report findings on self-reported cognitive functioning (SRCF) and quality of life (QoL). Patients with SCLC were randomized to receive PCI with or without HA (NCT01780675) and assessed at baseline (82 HA-PCI and 79 PCI patients) and at 4, 8, 12, 18, and 24 months of follow-up, using the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and EORTC QLQ—brain cancer module (BN20). SRCF was assessed with the cognitive functioning scale of the EORTC QLQ-C30 and the Medical Outcomes Study questionnaire. A change of 10 points was used for minimal clinically important differences. Percentages of patients classified with having improved, stable, or deteriorated SRCF were compared between groups using chi-square tests. Changes in mean scores were analyzed using linear mixed models. There was no significant difference in the percentage of patients with deteriorated, stable, or improved SRCF between the treatment arms. Depending on the evaluated time point, 31% to 46% and 29% to 43% of patients in the HA-PCI and PCI arm, respectively, reported a deteriorated SRCF on the basis of the EORTC QLQ-C30 and Medical Outcomes Study. QoL outcomes were not significantly different between the study arms, except for physical functioning at 12 months (p = 0.019) and motor dysfunction at 24 months (p = 0.020). Our trial did not find beneficial effects of HA-PCI over PCI on SRCF and QoL. The cognitive benefit of sparing the hippocampus in the context of PCI is still a subject of debate.

23 August 2024 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
AHA.S. Huberts
A.S. Huberts
EAE.A.C. Albers
E.A.C. Albers
KLK.M. de Ligt
K.M. de Ligt
LKL.B. Koppert
L.B. Koppert
SSS.B. Schagen
S.B. Schagen
LPL.V. van de Poll-Franse
L.V. van de Poll-Franse